-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anakinra in Cytokine Release Syndrome (Cytokine Storm)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anakinra in Cytokine Release Syndrome (Cytokine Storm) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anakinra in Cytokine Release Syndrome (Cytokine Storm) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Itacitinib Adipate in Cytokine Release Syndrome (Cytokine Storm)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Itacitinib Adipate in Cytokine Release Syndrome (Cytokine Storm) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Itacitinib Adipate in Cytokine Release Syndrome (Cytokine...
-
Product Insights
Cytokine Release Syndrome (Cytokine Storm) – Drugs In Development, 2023
Global Markets Direct’s, ‘Cytokine Release Syndrome (Cytokine Storm) - Drugs In Development, 2023’, provides an overview of the Cytokine Release Syndrome (Cytokine Storm) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cytokine Release Syndrome (Cytokine Storm), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Storm Lake
Storm Lake is an Onshore Wind project located in Iowa, United States. The project is owned by ALLETE Inc and was developed by GE Renewable Energy. The project came online in 1999. Empower your strategies with our Storm Lake report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the...
-
Product Insights
NedPower Mount Storm
NedPower Mount Storm is an Onshore Wind project located in West Virginia, United States. The project is owned by Clearway Energy Inc and was developed by Dominion Energy Inc; Shell WindEnergy Inc. The project came online in 2008. Empower your strategies with our NedPower Mount Storm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – POLB-001 in Cytokine Release Syndrome (Cytokine Storm)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - POLB-001 in Cytokine Release Syndrome (Cytokine Storm) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. POLB-001 in Cytokine Release Syndrome (Cytokine Storm) Drug Details:...
-
Product Insights
Mount Storm Steam Turbine Power Plant
Mount Storm Steam Turbine Power Plant is a thermal project located in West Virginia, United States. The project is owned by Virginia Electric and Power Co. The project came online in 1965. Empower your strategies with our Mount Storm Steam Turbine Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
NewLikelihood of Approval Analysis for Neisseria meningitidis Infections
Overview How likely is it that the drugs in Neisseria meningitidis Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neisseria meningitidis Infections Overview Neisseria Meningitidis is a severe bacterial infection...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CPL-409116 in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CPL-409116 in Pulmonary Arterial Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CPL-409116 in Pulmonary Arterial Hypertension Drug Details: CPL-409116 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Acloproxalap in Allergic Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acloproxalap in Allergic Asthma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acloproxalap in Allergic Asthma Drug Details: Acloproxalap (ADX-629) is under development for...